Skip to main content
PCSA
NASDAQ Life Sciences

Processa Acquires Vidya Therapeutics with $200M PIPE to Advance BTK Inhibitor

Tom Rudovsky · Reported by Reuters
More coverage: Biotech Stocks · Healthcare
Sentiment info
Positive
Importance info
10
Price
$2.27
Mkt Cap
$8.442M
52W Low
$1.67
52W High
$14.243
52W Position info
36% above low
Off High info
84% below high
Rel. Volume info
2.1× avg
Market data snapshot near publication time

PCSA sits 36% above its 52-week low of $1.67 on elevated volume (2.1× avg).

Summary

Processa Pharmaceuticals is acquiring Vidya Therapeutics and securing approximately $200 million in a concurrent private placement. The deal brings in VT-7208, a BTK inhibitor targeting multiple disease areas, transforming the pipeline. This follows a going concern warning in May and an urgent need for capital — the PIPE directly addresses the cash burn. The reverse merger effectively recapitalizes the company and shifts its strategic focus. With a market cap near $8.4 million, the $200 million financing is highly dilutive but provides a lifeline. The 8-K filed today confirms the transaction's completion.

At the time of this announcement, PCSA was trading at $2.27 on NASDAQ in the Life Sciences sector, with a market capitalization of approximately $8.4M. The 52-week trading range was $1.67 to $14.24. This news item was assessed with positive market sentiment and an importance score of 10 out of 10. Source: Reuters.


Price Chart

Share this article

Copied!

PCSA - Latest Insights

PCSA
Nov 05, 2026, 8:10 AM EST
Filing Type: 8-K
Importance Score:
7
Price at Filing: $1.85
Real-time Price: $1.81 info
Change: -$0.040 (-2%) info
Market Cap: $5.233M info
PCSA
Oct 29, 2026, 8:46 AM EDT
Filing Type: 8-K
Importance Score:
7
Price at Filing: $1.95
Real-time Price: $1.81 info
Change: -$0.140 (-7%) info
Market Cap: $5.233M info
PCSA
Oct 29, 2026, 8:00 AM EDT
Source: Wiseek News
Importance Score:
7
Price at Filing: $1.89
Real-time Price: $1.81 info
Change: -$0.080 (-4%) info
Market Cap: $5.233M info
PCSA
Oct 09, 2026, 4:03 PM EDT
Filing Type: PRE 14A
Importance Score:
7
Price at Filing: $1.47
Real-time Price: $1.81 info
Change: +$0.340 (+23%) info
Market Cap: $5.233M info
PCSA
Oct 09, 2026, 4:02 PM EDT
Filing Type: S-3
Importance Score:
7
Price at Filing: $1.47
Real-time Price: $1.81 info
Change: +$0.340 (+23%) info
Market Cap: $5.233M info